ORBIMED ADVISORS LLC
Director; Director, 10% Owner · 5 filings · Latest: Jul 27, 2026
Q32 Bio Inc.
Scribe Therapeutics, Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SCTX | ORBIMED ADVISORS LLC | Director | Jul 27, 2026 | Purchase | $15.00 | 1,000,000 | $15.0M | 1,348,825 | |
QTTB | ORBIMED ADVISORS LLC | Director, 10% Owner | May 28, 2026 | Purchase | $8.00 | 1,875,000 | $15.0M | 625,000 | |
SION | ORBIMED ADVISORS LLC | Director | May 27, 2026 | Sale | $44.49 | 101 | $4.5K | 2,671,721 | |
SION | ORBIMED ADVISORS LLC | Director | May 11, 2026 | Sale | $46.22 | 184,639 | $8.5M | 2,671,822 | |
SION | ORBIMED ADVISORS LLC | Director | May 8, 2026 | Sale | $44.58 | 59,767 | $2.7M | 2,856,461 | |
SION | ORBIMED ADVISORS LLC | Director | May 7, 2026 | Sale | $44.61 | 48,546 | $2.2M | 2,916,228 |